Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Biotechnology     Life Sciences Research     Genomics     Isothermal Nucleic Acid Amplification     Isothermal Nucleic Acid Amplification    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

North America Isothermal Nucleic Acid Amplification Market

  • Report Code: IS 1000
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

According to the World Health Organization (WHO), an ideal diagnostic test that is suitable for developing countries should be ASSURED—Affordable, Sensitive, Specific, User friendly, Robust and rapid, Equipment-free, and Deliverable to the end user. The isothermal nucleic acid amplification has recently drawn the attention of the global scientific community by meeting the ASSURED guidelines through its distinct features, including its ability to operate in single-digit temperatures. A variety of isothermal nucleic acid amplification based diagnostic platform have been discovered to provide Point-of-Care (POC) Testing at low resource settings.

 

Isothermal amplification technologies display a number of properties that prove their capabilities in addressing the current hurdles in the development of diagnostic products for POCT in low resource settings (LRS).

 

The Nucleic acid amplification technologies are used in the field of molecular biology and recombinant DNA technologies. These techniques are used as leading methods in detecting and analyzing a small quantity of nucleic acids. Nucleic acid-based testing has been aided by PCR and its variant. However, owing to its stringent requirements like thermo cycling, its uses are limited to laboratory settings. This has led to the emergence of a number of novel technologies collectively termed as Isothermal Nucleic Acid Amplification Technology.

 

 

North America accounts for the largest market share of the isothermal nucleic acid amplification market globally in 2013. The market value was pegged at $240 million in 2013 and is expected to grow at a CAGR of 15.9% from 2014 to 2019.

It has strong presence in the U.S., and Canada. There have been huge investment activities focusing on the research and development of Isothermal nucleic acid amplification to attract attention from biotechnology firms and academic institutes. Investments have led to active partnerships, collaborations, and acquisitions in the Isothermal nucleic acid amplification technology space  

Isothermal amplification-based technologies and their variants are developed for the diagnosis of various infectious disease-causing pathogens. The increase in miniaturization of nucleic acid-based diagnostics will enhance the growth of the market. High incidence rate of various infectious diseases, need for prompt diagnosis and faster treatment,

The key players in this market are Hologic Gen-Probe (U.S.), bioMerieux (France), BD Diagnostics (U.S.), QIAGEN (Netherlands), Alere (U.S.), Eiken Chemical (Japan), Meridian Bioscience (U.S.), and BioHelix (Quidel) (U.S.). The analysis has identified that licensing agreements, collaboration with research institutes, and acquisitions are the major strategies of key players in the North American isothermal nucleic acid amplification market.

 

On the basis of applications the market is segmented into In Vitro diagnostics, Drug discovery, Academics, Agrigenomics, and Personalized medicine. The market is further segmented and forecasted on the basis of major countries, such as U.S., Canada, and Mexico.

 

The report captures an extensive competitive landscape of companies which have major share in this market. This report also includes the market share, value chain analysis, future trends and upcoming opportunities in the market. An impact analysis of the major drivers, restraints, and challenges influencing the adoption and growth of North American isothermal nucleic acid amplification market during the period of 2012 to 2019 is also covered.

 

 



1 Introduction

1.1 Objective of the study

1.2 Market Definition and Scope of the study

1.3 Markets Covered

1.4 Stakeholders

 

2 Research Methodology

2.1 INTEGRATED ECOSYSTEM OF Isothermal Nucleic Acid Amplification-North America

2.2 ARRIVING AT Isothermal Nucleic Acid Amplification-North America MARKET SIZE

2.2.1 TOP DOWN APPROACH

2.2.2 BOTTOM-UP APPROACH

2.2.3 DEMAND (CONSUMPTION) SIDE ANALYSIS

2.2.4 Macro indicators

2.3 Assumptions

 

3 EXECUTIVE SUMMARY

 

4 MARKET OVERVIEW

4.1 Introduction

4.2 Comparison with Genomics (Parent) Market

4.3 Market Drivers and Inhibitors

4.4 Demand Side Analysis

4.5 Vendor Side Analysis

 

5 Isothermal Nucleic Acid Amplification-North America, By Application

5.1 Research Methodology

5.2 Introduction

5.3 Demand Side Analysis

5.4 Vendor Side Analysis

5.5 In Vitro Diagnostics

5.6 Drug Discovery

5.7 Academics

5.8 Agri-genomics

5.9 Personalized Medicine

5.10 Other Applications

5.11 SNEAK VIEW: Genomics (Parent) Market, By Application

 

6 Isothermal Nucleic Acid Amplification-North America, By Product

6.1 Research Methodology

6.2 Introduction

6.3 Comparison with Genomics (Parent) Market

6.4 Vendor Side Analysis

6.5 Isothermal Nucleic Acid Amplification Reagents

6.6 Isothermal Nucleic Acid Amplification Instruments

6.7 Isothermal Nucleic Acid Amplification Services

6.8 Sneak View: Genomics (Parent) Market, By Product

 

7 Isothermal Nucleic Acid Amplification-North America, By Technology

7.1 Research Methodology

7.2 Introduction

7.3 Comparison with Genomics (Parent) Market

7.4 Vendor Side Analysis

7.5 Other INAAT Technologies

7.6 Helicase-dependent amplification (HDA)

7.7 Loop-mediated isothermal amplification (LAMP)

7.8 Nucleic acid sequence based amplification (NASBA)

7.9 Transcription-mediated amplification (TMA)

7.10 Single primer isothermal amplification(SPIA)

7.11 Strand displacement amplification (SDA)

7.12 Sneak View: Genomics (Parent) Market, By Technology

 

8 Isothermal Nucleic Acid Amplification- North America, By Geography

8.1 Research Methodology

8.2 Introduction

8.3 Vendor Side Analysis

8.4 North America - Isothermal Nucleic Acid Amplification Market

8.4.1 North America - Isothermal Nucleic Acid Amplification Market, By Application

8.4.2 North America - Isothermal Nucleic Acid Amplification Market, By Product

8.5 The U.S. - Isothermal Nucleic Acid Amplification Market

8.5.1 The U.S. - Isothermal Nucleic Acid Amplification Market, By Application

8.5.2 The U.S. - Isothermal Nucleic Acid Amplification Market, By Product

8.6 Canada - Isothermal Nucleic Acid Amplification Market

8.6.1 Canada- Isothermal Nucleic Acid Amplification Market, By Application

8.7.2 Canada- Isothermal Nucleic Acid Amplification Market, By Product

8.8 Mexico- Isothermal Nucleic Acid Amplification Market

8.8.1 Mexico Isothermal Nucleic Acid Amplification Market, By Application

8.8.2  Mexico Isothermal Nucleic Acid Amplification Market, By Product

8.9 North America - Other Geographies Isothermal Nucleic Acid Amplification Market

8.9.1 North America - Other Geographies Isothermal Nucleic Acid Amplification Market, By Application

8.9.2 North America - Other Geographies Isothermal Nucleic Acid Amplification Market, By Product

8.4 SNEAK VIEW: Genomics (Parent) Market, By Geography

 

 9. Competitive Landscape

 

9.1.1 Merger & Acquisition

9.1.2 Other Expansion

9.1.3 New Synergies

 

10 Isothermal Nucleic Acid Amplification-North America, By Company

10.1 Becton Diagnostics Segment

10.1.1 Revenue Mix for 2013

10.1.2 Historical Revenue Data

10.1.3 Product and Service Offerings

10.1.4 Key Developments

10.1.5 MMM Analysis

10.2  BioHelix Corporation

10.2.1 Revenue Mix for 2013

10.2.2 Historical Revenue Data

10.2.3 Product and Service Offerings

10.2.4 Key Developments

10.2.5 MMM Analysis

10.3 BioMérieux

10.3.1 Revenue Mix for 2013

10.3.2 Historical Data

10.3.3 Product and Service Offerings

10.3.4 Key Developments

10.3.5 MMM Analysis

10.4  Hologic Gen-Probe Incorporated

10.4.1 Revenue Mix for 2013

10.4.2 Historical Data

10.4.4 Product and Service Offerings

10.4.5 Key Developments

10.4.6 MMM Analysis

10.5 F. Meridian Bioscience, Inc.

10.5.1 Revenue Mix for 2013

10.5.2 Historical Data

10.5.3 Product and Service Offerings

10.5.4 Key Developments

10.5.5 MMM Analysis

10.6 Novartis AG

10.6.1 Revenue Mix for 2013

10.6.2 Historical Data

10.6.3 Product and Service Offerings

10.6.4 Key Developments

10.6.5 MMM Analysis

10.6 Ustar Biotechnologies Ltd.

10.6.1 Revenue Mix for 2013

10.6.2 Historical Data

10.6.3 Product and Service Offerings

10.6.4 Key Developments

10.6.5 MMM Analysis

 

11 APPENDIX

 

Please fill in the form below to receive a free copy of the Summary of this Report
















North America Isothermal Nucleic Acid Amplification Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Connect With Us
US/CAN : +1-888-502-0539